Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 49,484 shares of the business’s stock in a transaction dated Thursday, September 22nd. The shares were sold at an average price of $60.18, for a total transaction of $2,977,947.12. Following the completion of the sale, the chief executive officer now directly owns 158,911 shares of the company’s stock, valued at approximately $9,563,263.98. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of Masimo Corp. (NASDAQ:MASI) opened at 58.58 on Friday. The stock’s 50 day moving average is $58.89 and its 200-day moving average is $50.60. The company has a market cap of $2.89 billion, a P/E ratio of 30.72 and a beta of 0.80. Masimo Corp. has a one year low of $33.03 and a one year high of $60.52.
Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.16. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The company had revenue of $172.64 million for the quarter, compared to analyst estimates of $166.02 million. During the same period last year, the firm earned $0.36 earnings per share. The firm’s revenue was up 10.9% on a year-over-year basis. Equities research analysts forecast that Masimo Corp. will post $2.02 earnings per share for the current year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. PineBridge Investments L.P. raised its position in Masimo Corp. by 2.7% in the second quarter. PineBridge Investments L.P. now owns 5,591 shares of the company’s stock worth $293,000 after buying an additional 149 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. raised its position in Masimo Corp. by 0.7% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 56,685 shares of the company’s stock worth $2,372,000 after buying an additional 400 shares during the last quarter. Teachers Advisors Inc. raised its position in Masimo Corp. by 0.7% in the second quarter. Teachers Advisors Inc. now owns 65,736 shares of the company’s stock worth $3,452,000 after buying an additional 460 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in Masimo Corp. by 1.6% in the second quarter. UBS Asset Management Americas Inc. now owns 28,855 shares of the company’s stock worth $1,515,000 after buying an additional 467 shares during the last quarter. Finally, UBS Group AG raised its position in Masimo Corp. by 3.6% in the first quarter. UBS Group AG now owns 19,177 shares of the company’s stock worth $802,000 after buying an additional 663 shares during the last quarter. 79.88% of the stock is currently owned by institutional investors.
A number of analysts have issued reports on the stock. Piper Jaffray Cos. reissued an “overweight” rating and issued a $55.00 price objective (up previously from $52.00) on shares of Masimo Corp. in a report on Friday, August 5th. BTIG Research reissued a “hold” rating on shares of Masimo Corp. in a report on Friday, August 5th. Finally, Wedbush reissued an “outperform” rating and issued a $63.00 price objective (up previously from $60.00) on shares of Masimo Corp. in a report on Thursday, August 4th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $52.60.
Masimo Corp. Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.